Carnick & Kubik’s Aoxing Pharmaceutical AXN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXN
RCM
Carnick & Kubik's AXN Position: Q4 2015 in Review
Carnick & Kubik sold out of Aoxing Pharmaceutical (AXN) in Q4 2015, closing a stake of 150 shares — an estimated $222 sold.
Carnick & Kubik first reported a position in AXN in Q3 2015 and held it in 1 quarter. The position peaked at $222 in Q3 2015. 14 funds tracked by Wall St. Rank hold AXN as of Q4 2015.
- Carnick & Kubik reported no remaining Aoxing Pharmaceutical position as of Q4 2015 after selling out during the quarter.
- Carnick & Kubik sold 150 Aoxing Pharmaceutical shares in Q4 2015, an estimated $222.
- Carnick & Kubik first reported a position in Aoxing Pharmaceutical in Q3 2015 and held it in 1 quarter.
- Carnick & Kubik's Aoxing Pharmaceutical position peaked at $222 in Q3 2015.
- 14 funds tracked by Wall St. Rank held Aoxing Pharmaceutical as of Q4 2015.
Based on Carnick & Kubik's 13F filing for Q4 2015, filed 11 Feb 2016.